Windsor Clinical Research   Report issue

For profit Phase 3
Founded: Windsor ON Canada (2004)

Organization Overview

First Clinical Trial
2011
NCT01355458
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Windsor Clinical Research Inc.

Active Ingredients

Drugs in Phase 3 Trials (3)

acitretin (soriatane) (1 trial)

brimonidine (alphagan) (1 trial)

trifarotene (Aklief) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 3)

Dermatitis (Phase 3)

Erythema (Phase 3)

Rosacea (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3